Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 1
1967 1
1968 2
1969 1
1970 3
1971 2
1972 3
1973 4
1974 3
1975 1
1976 4
1977 2
1978 5
1979 4
1980 11
1981 8
1982 2
1983 11
1984 12
1985 5
1986 8
1987 15
1988 13
1989 6
1990 14
1991 20
1992 15
1993 12
1994 8
1995 8
1996 15
1997 10
1998 19
1999 8
2000 15
2001 6
2002 14
2003 15
2004 21
2005 24
2006 29
2007 26
2008 40
2009 25
2010 21
2011 17
2012 21
2013 25
2014 17
2015 20
2016 36
2017 40
2018 21
2019 24
2020 33
2021 35
2022 24
2023 33
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

779 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
Bardia A, Hurvitz SA, Tolaney SM, Loirat D, Punie K, Oliveira M, Brufsky A, Sardesai SD, Kalinsky K, Zelnak AB, Weaver R, Traina T, Dalenc F, Aftimos P, Lynce F, Diab S, Cortés J, O'Shaughnessy J, Diéras V, Ferrario C, Schmid P, Carey LA, Gianni L, Piccart MJ, Loibl S, Goldenberg DM, Hong Q, Olivo MS, Itri LM, Rugo HS; ASCENT Clinical Trial Investigators. Bardia A, et al. Among authors: ferrario c. N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485. N Engl J Med. 2021. PMID: 33882206 Clinical Trial.
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer.
O'Donnell PH, Milowsky MI, Petrylak DP, Hoimes CJ, Flaig TW, Mar N, Moon HH, Friedlander TW, McKay RR, Bilen MA, Srinivas S, Burgess EF, Ramamurthy C, George S, Geynisman DM, Bracarda S, Borchiellini D, Geoffrois L, Maroto Rey JP, Ferrario C, Carret AS, Yu Y, Guseva M, Homet Moreno B, Rosenberg JE. O'Donnell PH, et al. Among authors: ferrario c. J Clin Oncol. 2023 Sep 1;41(25):4107-4117. doi: 10.1200/JCO.22.02887. Epub 2023 Jun 27. J Clin Oncol. 2023. PMID: 37369081 Free PMC article. Clinical Trial.
Mother-to-Infant Microbial Transmission from Different Body Sites Shapes the Developing Infant Gut Microbiome.
Ferretti P, Pasolli E, Tett A, Asnicar F, Gorfer V, Fedi S, Armanini F, Truong DT, Manara S, Zolfo M, Beghini F, Bertorelli R, De Sanctis V, Bariletti I, Canto R, Clementi R, Cologna M, Crifò T, Cusumano G, Gottardi S, Innamorati C, Masè C, Postai D, Savoi D, Duranti S, Lugli GA, Mancabelli L, Turroni F, Ferrario C, Milani C, Mangifesta M, Anzalone R, Viappiani A, Yassour M, Vlamakis H, Xavier R, Collado CM, Koren O, Tateo S, Soffiati M, Pedrotti A, Ventura M, Huttenhower C, Bork P, Segata N. Ferretti P, et al. Among authors: ferrario c. Cell Host Microbe. 2018 Jul 11;24(1):133-145.e5. doi: 10.1016/j.chom.2018.06.005. Cell Host Microbe. 2018. PMID: 30001516 Free PMC article.
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial.
Mittendorf EA, Zhang H, Barrios CH, Saji S, Jung KH, Hegg R, Koehler A, Sohn J, Iwata H, Telli ML, Ferrario C, Punie K, Penault-Llorca F, Patel S, Duc AN, Liste-Hermoso M, Maiya V, Molinero L, Chui SY, Harbeck N. Mittendorf EA, et al. Among authors: ferrario c. Lancet. 2020 Oct 10;396(10257):1090-1100. doi: 10.1016/S0140-6736(20)31953-X. Epub 2020 Sep 20. Lancet. 2020. PMID: 32966830 Clinical Trial.
Alternative Renin-Angiotensin System.
Bader M, Steckelings UM, Alenina N, Santos RAS, Ferrario CM. Bader M, et al. Among authors: ferrario cm. Hypertension. 2024 May;81(5):964-976. doi: 10.1161/HYPERTENSIONAHA.123.21364. Epub 2024 Feb 16. Hypertension. 2024. PMID: 38362781 Free article. Review.
Preface.
Ferrario CM, Wang JG. Ferrario CM, et al. Ther Adv Cardiovasc Dis. 2016 Jun;10(3):116-7. doi: 10.1177/1753944716645029. Ther Adv Cardiovasc Dis. 2016. PMID: 27271311 Free PMC article. No abstract available.
Therapeutic Advances in Cardiovascular Disease. Editorial.
Irigoyen M, Thorne M, Ferrario CM. Irigoyen M, et al. Among authors: ferrario cm. Ther Adv Cardiovasc Dis. 2015 Aug;9(4):113-4. doi: 10.1177/1753944715599720. Ther Adv Cardiovasc Dis. 2015. PMID: 26335584 Free article. No abstract available.
Dopamine 'ups and downs' in addiction revisited.
Samaha AN, Khoo SY, Ferrario CR, Robinson TE. Samaha AN, et al. Among authors: ferrario cr. Trends Neurosci. 2021 Jul;44(7):516-526. doi: 10.1016/j.tins.2021.03.003. Epub 2021 Apr 20. Trends Neurosci. 2021. PMID: 33892963 Free PMC article. Review.
New angiotensins.
Varagic J, Trask AJ, Jessup JA, Chappell MC, Ferrario CM. Varagic J, et al. Among authors: ferrario cm. J Mol Med (Berl). 2008 Jun;86(6):663-71. doi: 10.1007/s00109-008-0340-4. Epub 2008 Apr 25. J Mol Med (Berl). 2008. PMID: 18437333 Free PMC article. Review.
COSEHC overview.
Ferrario CM. Ferrario CM. Am J Med Sci. 2004 May;327(5):233. doi: 10.1097/00000441-200405000-00001. Am J Med Sci. 2004. PMID: 15166739 No abstract available.
779 results